Big Pharma's AI Speedup Pitch Collides With Anthropic's Own Cost Math
Drugmakers say Anthropic-class AI is cutting discovery timelines just as falling AI prices squeeze the compute commitments behind that same technology.
The same AI capability that big pharmaceutical companies say is shrinking drug discovery timelines is, according to a separate account of Anthropic's finances, straining Anthropic's own compute commitments as AI prices fall.